Key statistics
Previous close$103.36
Open$100.23
Day high$105.63
Day low$97.15
52-week high$155.82
52-week low$71.35
Market cap4.43B
Volume426.08K
Average volume531.13K
P/E ratio74.52
Forward P/E—
EPS1.40
Dividend yield0.00%
Market context
Why it moved
IPGP rose after announcing a binding agreement to acquire Lumibird Medical for €300 million in cash, a deal that is expected to be accretive to gross margin, EBITDA, and adjusted EPS while nearly tripling its medical business and expanding its addressable market by approximately $1 billion, with Stifel reiterating its Buy rating and $125 price target in response.
What is happening
Recent company-specific developments and publisher coverage.
July 18, 2026IPG Photonics edged higher, outperforming a broader semiconductor sector rout, as investors digested the company's binding offer to acquire Lumibird Medical for €300 million (up to €350 million with earnout), announced July 16. The deal expands IPG's medical laser platform into ophthalmology alongside its existing urology business, adding ~$1 billion in addressable market and expected to be accretive to gross margin, EBITDA, and adjusted EPS — a company-specific catalyst that helped insulate shares from a sector-wide selloff that saw the iShares Semiconductor ETF (SOXX) fall ~5% on the day amid investor concern over AI capex sustainability and stretched valuations.0.9385
July 17, 2026IPG Photonics fell sharply, dragged lower by a broad semiconductor sector selloff even as the company announced a binding offer to acquire Lumibird Medical for €300 million, expanding its medical laser platform into ophthalmology. The sector-wide decline was fueled by TSMC's record Q2 earnings beat being overshadowed by a capex guidance hike to $60–$64 billion and margin warnings, sparking a valuation de-rating across chip stocks that pulled IPG down alongside peers despite the acquisition being described as accretive to gross margin, EBITDA, and adjusted EPS.-4.2165
July 15, 2026IPG Photonics closed higher, outperforming several semiconductor peers on a choppy day for chip stocks, as investors continue to weigh conflicting valuation signals. Analyst narratives point to a fair value of ~$130.50 — implying roughly 23% upside — driven by growth initiatives in medical, semiconductor, and micromachining end-markets, as well as a ~$10M Lockheed Martin order for its CROSSBOW high-energy laser counter-drone systems. In after-hours trading, shares slipped back modestly, while the broader tech sector (XLK) held essentially flat. Investors remain cautious given elevated R&D spend, softer core materials processing demand, and a broader semiconductor sector that has shed over 11% from its June record high.1.343
July 15, 2026IPG Photonics closed modestly higher, outperforming some semiconductor peers as a cooler-than-expected June CPI report (headline inflation falling to 3.5%) lifted growth and tech stocks broadly. The session's gains came despite the stock trading 13% below its post-Q1 earnings level, after a mixed quarter in which revenues rose 16.6% year-over-year to $265.5M and beat estimates, but EPS fell significantly short. Investors continue to weigh whether the stock — seen as roughly 19% undervalued relative to a DCF fair value estimate of ~$130 — represents a genuine opportunity or a value trap, with new growth in medical, semiconductor, and micromachining markets offering diversification but near-term margin pressure persisting.1.671
July 14, 2026IPG Photonics fell nearly 3% as a broad semiconductor selloff weighed on the stock, driven by U.S.-Iran tensions sending oil prices surging and rattling risk sentiment across tech and chip names. A Yahoo Finance analysis noted the stock looks undervalued on a DCF basis but that broader fundamental checks disagree, reflecting investor caution ahead of a pivotal Q2 earnings season where tech companies face elevated expectations and potential margin compression.-2.7847
July 10, 2026IPG Photonics surged roughly 5.6%, recovering sharply as semiconductor sentiment rebounded after last week's sector-wide selloff triggered by Samsung's record but disappointing-to-investors earnings and DeepSeek AI chip concerns. The bounce follows a brutal stretch that saw IPGP fall 8.6% in a single session and drop about 18% over 90 days, yet the stock remains ~30% below its February 52-week high of $153.91. A Simply Wall St analysis flagged the stock as potentially 22% undervalued against a fair value estimate of $130.50, offering a valuation catalyst, though analyst downgrades citing stretched earnings expectations and tariff/geopolitical risks temper optimism ahead of the upcoming earnings season.5.6218
July 8, 2026IPG Photonics surged nearly 6% during the regular session, staging a strong rebound alongside a broader semiconductor recovery after the prior session's sector-wide selloff — triggered by Samsung's record earnings being deemed insufficient to justify elevated AI valuations and reports that DeepSeek is developing its own chip. The bounce came despite a Seeking Alpha analyst downgrading IPGP on lowered earnings expectations and stretched valuation, with shares pulling back roughly 2% in after-hours trade as geopolitical risk resurfaced, with U.S.-Iran military exchanges threatening oil supply through the Strait of Hormuz and weighing on risk appetite ahead of Fed minutes.5.8799
July 8, 2026IPG Photonics tumbled sharply, hit by a company-specific analyst downgrade on top of a brutal sector-wide selloff. A Seeking Alpha analyst cut the rating citing lowered earnings expectations and a stretched valuation — the stock's PEG ratio has moved well above industrial peer norms following its 46% YTD rally — raising doubts about whether growth can justify current price levels. The downgrade compounded broader semiconductor pressure, as Samsung's record Q2 earnings still disappointed investors on valuation grounds, triggering a sector-wide rout that sent the Philadelphia Semiconductor Index down over 5%, with Morgan Stanley also advising clients to reduce semiconductor exposure as earnings momentum peaks.-7.7364
marketscreener.com · July 17, 2026IPG Photonics to Acquire Lumibird Medical for Up to 350 Million Euros to Expand Medical Laser Business↗Investing.com · July 17, 2026Stifel reiterates Buy on IPG Photonics stock after acquisition deal↗GlobeNewswire · July 16, 2026IPG Photonics Announces Binding Offer to Acquire Lumibird Medical, Expanding IPG’s Medical Laser Growth Platform↗StockStory · May 5, 2026Why IPG Photonics (IPGP) Shares Are Getting Obliterated Today↗Investing.com · May 5, 2026Earnings call transcript: IPG Photonics Q1 2026 beats forecasts, stock drops↗GlobeNewswire · May 5, 2026IPG Photonics Announces First Quarter 2026 Financial Results↗ Mt Newswire · July 17, 2026IPG Photonics to Acquire Lumibird Medical for Up to 350 Million Euros to Expand Medical Laser BusinessBenzinga · July 16, 2026IPG Photonics Enters Into A Binding Offer To Acquire Lumibird Medical For A Purchase Price Of €300M On A Cash-Free, Debt-free Basis; Co. Expects Deal Also Adds About $1B In Addressable Market For Advanced SolutionsMt Newswire · May 26, 2026Ipg Photonics Insider Sold Shares Worth $1,195,098, According to a Recent SEC FilingBenzinga · May 6, 2026Citigroup Maintains Buy on IPG Photonics, Raises Price Target to $150Mt Newswire · May 6, 2026Research Alert: CFRA Maintains Hold Rating On Shares Of Ipg Photonics CorporationBenzinga · May 6, 2026Needham Upgrades IPG Photonics to Buy, Announces $110 Price TargetBenzinga · May 5, 2026What's Going On With IPG Photonics Stock Today?Mt Newswire · May 5, 2026Update: IPG Photonics Shares Drop After Q1 Adjusted Earnings Fall
